- Forest mushroom
- Pasania fungus
- Hua gu
For Patients & Caregivers
Only a few studies have evaluated shiitake mushroom extract, with mixed results. Lentinan, a polysaccharide extracted from shiitake, may help extend the survival of patients with some cancers when used with chemotherapy, but additional studies are needed.
Some of the medicinal properties of shiitake mushroom are attributed to a sugar molecule named lentinan, on which extensive research has been done. In laboratory tests, lentinan does not kill cancer cells directly, but enhances a number of aspects of the immune system, which may aid in the slowing of tumor growth. Lentinan also kills viruses and microbes directly in laboratory studies. Most studies involving lentinan involve intravenous or intramuscular injections. It is uncertain whether the ingestion of shiitake mushrooms provides similar effects. One clinical trial has shown shiitake extract alone is not an effective treatment for prostate cancer. More studies are needed.
To prevent and treat cancer
A shiitake extract was found to be ineffective for the treatment of prostate cancer. However, an oral formulation of lentinan was shown to be effective in extending survival in patients with stomach, colorectal, pancreatic, and liver cancers. Larger studies are needed to confirm this effect.
To lower high cholesterol
Compounds in shiitake have cholesterol-lowering effects in lab studies, but there is no proof from clinical trials of their ability to also lower cholesterol in people.
To stimulate the immune system
Lentinan stimulates the activity of certain immune cells in lab studies and in people. However, it is unclear if lentinan or shiitake are effective in treating diseases such as AIDS and cancer.
To treat infections
Although lab studies suggest antiviral and antibacterial properties, there is no scientific evidence to support this use in humans.
For Healthcare Professionals
Shiitake mushroom, native to East Asia, is cultivated worldwide for its purported health benefits. The fresh and dried forms of the mushroom are commonly used in East Asian cooking. It is also valued as an anticancer agent.
Lentinan (1,3 beta-D-glucan), a polysaccharide isolated from shiitake is thought to be responsible for the mushroom’s beneficial effects. Although it has been shown to have anticancer effects (1) (34) (35) (36), lentinan is considered a biological response modifier, rather than having a direct cytotoxic effect on tumor cells (37). Studies conducted with shiitake extracts in vitro and in animal models reveal immunostimulatory (4), antiviral (31), hepatoprotective (5) (38), antihypercholemic (39), antiproliferative (4), cytotoxic (21), antimutagenic (6), and anticaries (7) properties. Latcripin-13 domain isolated from shiitake was shown to exhibit antitumor activity in lung cancer cells (40).
In a randomized dietary intervention in young adults, eating shiitake mushrooms for 4 weeks altered immune function (41). An orally administered shiitake mycelial extract decreased the incidence of chemotherapy-associated adverse effects in a small study of patients with advanced gastrointestinal cancer (22), and in combination with immunotherapy, improved QOL in cancer patients (48). But a polysaccharide/oligosaccharide complex from shiitake extract failed to show effectiveness in the treatment of prostate cancer (8). More well-designed studies are needed to establish shiitake as a useful adjunct to cancer treatment.
Shiitake mushroom supplementation enhanced gut immunity by upregulating interleukin (IL)-23 secretion in a murine model of acute dextran sodium sulfate-colitis (29). Shiitake extracts and the polysaccharide lentinan exerted antiviral effects, by acting on initial replication processes of poliovirus type 1 (PV-1) and bovine herpes virus type 1 (BoHV-1) (31). Another polysaccharide isolated from shiitake exhibited antibacterial effects in mice by increasing T-helper (Th1) cell immunity, resulting in activation of macrophage-mediated immune response (32). The isolated protein lentin exhibited antifungal properties, inhibited proliferation of leukemic cells, and suppressed activity of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (3). Shiitake consumption in adults altered immune function via increased proliferation of gamma delta-T and NK-T cells, increased secretory immunoglobulin A in saliva, increased IL-1alpha, IL-4, IL-10, and tumor necrosis factor (TNF)-α levels, and decreased macrophage inflammatory protein-1alpha/chemokine C-C ligand 3 (MIP-1alpha/CCL3) levels (41). A low-molecular-weight lignin from shiitake inhibits hepatitis C virus by binding to viral apolipoprotein E (apoE) before interacting with cell surface heparan sulfate (38).
Eritadenine from shiitake may exert antihypercholemic effects and regulate lipid metabolism by inhibiting S-adenosyl homocysteine hydrolase activity, and both eritadenine and shiitake mushroom supplementation upregulated CYP7A1 mRNA expression which was decreased in hypercholesterolemic mice (39). High doses of shiitake mushroom prevented obesity in rats by increasing plasma triacylglycerol accumulation in the liver (30).
Dried shiitake extract caused apoptosis in human hepatocellular carcinoma (HepG2) cells by mediating caspase-3 and -8 pathways (21). Inhibition of lung cancer cells by the Latcripin-13 domain isolated from shiitake was shown to be due to apoptotic induction (40). Anticancer effects of the polysaccharide lentinan (1,3 beta-D-glucan) may be due to its ability to suppress cytochrome P450 1A enzymes that are known to metabolize procarcinogens to active forms (2). Polysaccharides SLNT1 and JLNT1 isolated from the mushroom also demonstrated antitumor effects by increasing serum IL-2 levels and TNF-α production, and by inducing apoptosis in tumor cells in mice (33).
Shiitake dermatitis, flagellate erythema: Patterns of whiplike, linear, erythematous wheals after consumption of raw or even cooked shiitake mushrooms which has been associated with toxic reactions to the constituent lentinan (24) (25) (26) (27) (42) (43) (44) (45) (46) (47) (49).
Intermittent dermatitis over a 16-year period: Linked to consumption of shiitake mushrooms in a 45-year-old male (19).
Esophageal symptoms: Linked to a food allergy in a 37-year-old man following consumption of shiitake mushroom (20).
Small bowel obstruction: Caused by ingestion of a whole shiitake mushroom, resulting in necrosis and mucosal damage in the small intestine (28).